Forty years ago clinical laboratories could analyse very few biochemical constituents in peripheral blood, and urine testing was widely used as an aid to diagnosis. This was usually left to nurses and medical students who often used out-of-date or even wrongly prepared reagents and dirty test tubes, with misleading results. In 1962 a leading article in the Lancet! summarised the position as follows: 'Urine-testing in the wards emerges as a marginally more exact science than palmistry, but not one which could fairly be compared to an intelligent game of noughts and crosses. ' Although the development of sensitive plasma (or serum) assays should have reduced the need for urine testing. great stress is still laid on analysis of urine in teaching and examining nurses, medical students, and junior doctors; the clinical value of the results is hardly considered. The persistence of this idee 'fixe despite the availability of the more sensitive and specific plasma assays may be due to the concomitant development of commercially prepared reagent strips and tablets for urine testinga development probably motivated more by technical feasibility than clinical need. Their use has become popular because they incorporate standardised reagents; they eliminate the need for bunsen burners and for washing test tubes; they have simplified methods, and they should have improved the reliability of the results. Nevertheless the tests are still often badly performed, despite the stress laid on training and despite the clear instructions and warnings issued by manufacturers (for examples) about the proper use and storage of their products and about the likely causes of artefactual results. The use of multireagent strips requires accurate timing of the sequential readings" and may have increased the number of false results. Although a comprehensive quality-control programme for qualitative analysis of urine has recently been described.! usually neither those performing the tests nor the reagent strips themselves are subjected to the internal quality control now thought to be an essential part of the practice of any good clinical chemistry laboratory.
The table lists the prices at the end of 1980 of most of the commercially available tests. Fraser et al. 5 calculated that in Australia in 1977 about $(Austral) I 250 000 (approximately £624 (00) was spent on dipsticks alone; the cost of collection containers and the staff time involved would at least double this sum. Sandler" found that routine urine testing contributed useful clinical information in very few cases indeed and deplored the consequent waste of money; his conclusions are in close agreement with those of other series. in which, in addition, it was found that the results were apparently often ignored," 7 The fact that the result of a test is not noted does not necessarily mean that its performance was unnecessary; however, the critical observer should exclude this, or the equally undesirable possibility that important clinical information is not reaching its target. If the result has been carefully considered by the clinician and has then been deliberately rejected as irrelevant in the light of the overall evidence, the estimation may have been worthwhile. With this in mind. the possible clinical value of routine screening will first be discussed for the major biochemical constituents in turn. The usefulness of multi reagent strips in terms of clinical value and costs will then be considered.
It must be stressed that this paper is primarily concerned with routine, unselective screening. Testing for individual constituents on a selected population can often be more useful. concentrations above about 5·5 mmol/l. Glycosuria of this degree occurs in only two circumstances.
Value of tests for individual constituents GLUCOSE

Glucose can be detected by routine testing at urinary
1 The renal tubular reabsorptive capacity for glucose may be lower than 'normal'. The consequent 'renal glycosuria' is usually harmless and is relatively common, especially during pregnancy.
2 The renal tubular reabsorptive capacity may be normal, but plasma levels of glucose may' have exceeded about 10 rnmol/l at some time since the last urine specimen was passed. Fasting glycosuria of this type indicates moderate to severe diabetes mellitus, which is likely to be suggested by the clinical history. Glycosuria present only after meals may be associated with less severe, and possibly symptomless, diabetes. A case could therefore be made for routine testing for glucose provided that the urine specimen is taken from a non-fasting patient. The timing of the test in relation to meals can be fairly easily controlled in inpatients, but a compromise may have to be reached in outpatient clinics when 'random' specimens may have to be tested initially. The quality control procedures outlined later must be followed if reliable results are to be obtained.
Unless positive results are acted on, such testing is a waste of money; Fraser et al. s found that, in a series of 182 patients undergoing routine urine screening, clinicians ignored the finding in one-third of the 28 patients with glycosuria. Any patient found to have glycosuria must be further investigated.
REDUCING SUBSTANCES
Many urinary metabolites associated with inborn errors of metabolism are 'reducing substances', and the urine of newborn infants should be routinely tested for these constituents. Positive findings must be confirmed and the metabolite identified. It is important to remember that negative results in very ill infants do not exclude such disease, since the metabolite may not be excreted at the time of testing; for instance, cases of galactosaemia without galactosuria have been described. 8 In adults, tests for reducing substances may help in the control of insulin dosage in known diabetics. The use of tests for 'reducing substances' is not indicated for screening adults. KETONES A case could be made for screening the urine of newborn infants for ketones, because some inborn errors of metabolism are associated with ketonuria.
Screening tests with reagent strips should not be relied upon if there is clinical suspicion of such a disease: the presence or absence of ketonuria must then be confirmed by the laboratory.
In adults, mild ketonuria, unless associated with obvious symptoms, is most commonly due to fasting; it is then of no clinical significance. In pregnant women, who are vomiting or undergoing prolonged labour, the finding of ketonuria confirms their need for a parenteral energy supply. The patient with diabetic ketonuria is usually very ill, and the need for testing will be indicated by the clinical picture. Routine screening of non-pregnant adult patients for ketonuria is unlikely to yield useful clinical information.
PROTEIN AND BLOOD
A weakly positive test for urinary protein in a symptomless patient is most likely to be due to contamination of the urine from the perineum. Menstruation must always be excluded as a cause of apparent haematuria and proteinuria in women.
Slight proteinuria is a non-specific finding in most pyrexial illnesses and in congestive cardiac failure; it is then of no diagnostic significance. The gross proteinuria found in the nephrotic syndrome is likely to be suggested by the clinical picture.
Microscopy and microbiological examination of the urine are essential in patients with a suspected urinary infection and are much more useful than testing for protein. Microscopy for casts is also more useful in detecting chronic renal disease; if this diagnosis is suspected, plasma urea and/or creatinine assays must be performed. It should be remembered that Bence Jones protein will not be detected by strip methods.
There is no need to test for haematuria if blood is visible to the naked eye. There are usually clinical indications suggesting the need to test for the occult haematuria which may be found in patients with acute glomerulonephritis or with stones. A case might be made, however, for screening for haematuria to detect an unsuspected neoplasm of the urinary tract.
Fraser et 0/. 5 found that, out of 182 patients in whom routine urine testing was carried out, the clinicians ignored the finding of 'proteinuria' in 23 out of 37. and of 'haematuria' in 29 out of 49 patients-possibly because the cause was known to be artefactual (an 'unclean' specimen or contamination with menstrual blood). In most of the remaining cases the diagnosis was already clear. In only two patients (one with proteinuria and one with haematuria) did the information lead to a reassessment of the diagnosis. These findings suggest that routine screening for urinary protein and blood is usually clinically unrewarding; however, some may consider that the value might have been greater if more results had been acted on, or that even such a small yield is worth the extra cost.
BILIRUBIN AND UROBILINOGEN
Tests for bile constituenrs in the urine are much less informative than the plasma assays used to detect liver disease.
The excretion of bilirubin in the urine is a reflection of the plasma level of conjugated bilirubin, and urine testing is almost never indicated.
Urinary urobilinogen excretion is very variable in normal subjects and depends, among other factors, on the pH of the urine," It is of no diagnostic value as a test for liver disease. Intravascular haernolysis so gross as to cause unequivocally high urobilinogen excretion is likely to be suspected on clinical and haematological grounds.
URINARY pa
Urinary pH depends on many factors, including Zi/va diet, and is very variable in normal subjects. Measurement is indicated, under strictly controlled conditions and with a knowledge of the blood findings, only to diagnose renal tubular acidosis, and in such cases pH electrodes should be used; it has no place as a screening test.
MULTIREAGENT STRIPS
Manufacturers have now adjusted the price of multireagent strips so that, if more then one test is to be performed, it is cheaper to do them simultaneously than individually (Table) . This is often false economy because testing for a single constituent is even cheaper, and it is unnecessary to screen for most of them. We have suggested that screening for urinary pH and bilirubin are hardly even of clinical value, and yet a pH indicator is included in many strips, and bilirubin in two. In adults, only routine screening for the presence of glucose in a postprandial specimen is of proven clinical value, and, if this is accepted, the purchase of multireagent strips is a waste of money. If, however, screening for protein and blood were also to be considered desirable, it is cheaper to use Hemacombistix than to test for each constituent individually. Whether the unexpected finding of a trace of proteinuria is clinically significant merits critical consideration."
A case may be made for incorporating a pH indicator into reagent strips for testing for protein; very alkaline or very acid urine may yield false positive or negative results, respectively.
QUALITY CONTROL
Urine testing, which is justified either as a routine screen, or because it is indicated on clinical grounds, should be subjected to quality control procedures as stringent as those for any laboratory test. The following precautions are essential.
1 Strips and tablets must be stored as directed by the manufacturers and discarded by the expiry date.
2 Regular checks should be made by the laboratory, using standard solutions on sample strips from each batch, to ensure that they are likely to yield valid results if used correctly.
3 The risk of contamination from the perineum should be minimised by careful collection techniques.
4 Only freshly passed urine specimens should be tested.'! 5 Artefactual causes of false positive and negative reactions must be eliminated (for instance, urine containers must be free of traces of bleach or detergents). 6 The instructions for use must be carefullv followed, and particular attention should be paid to the timing of the readings. The operator should occasionally test a quality control specimenpreferably one which is indistinguishable from a patient's specimen.
7 Positive findings must be confirmed and followed up.
If the test is clinically indicated, it is important that the answer is correct and that the cause of positive results be sought. Testing that is not indicated is a waste of money.
Conclusions
In adults, routine qualitative biochemical urine testing is probably indicated only for glycosuria in a specimen preferably taken from a non-fasting subject: in outpatient clinics, tests may have to be performed on 'random' specimens, but an attempt should be made to find out the time of the last meal. In newborn infants, screening for urinary reducing substances and ketones may be valuable. Some may think that testing for protein and blood should be routine. Other tests may be indicated on clinical grounds, but some (such as bilirubin) are hardly ever useful. Purchase of strips incorporating reagents for simultaneous testing for many constituents (except, perhaps, Hemacombistix) is therefore uneconomical.
Urine testing has been said to be helpful to those without easy access to laboratory facilities. In many cases this argument is false, because adequate quality control is possible only with the help of a reliable laboratory, and wrong results are always more dangerous than none. However, in some remote areas, hospitals and practitioners may have access to such quality control on, say, a weekly basis although they may not have immediate access to the laboratory facilities for blood testing: in such circumstances selective urine testing, with a full knowledge of its shortcomings, may be useful.
